NASDAQ NMS - GLOBAL MARKET · CRMD
-0.64% · -$0.0478 · Vol 842.6K
Market closed · last close 4:00 PM ET · price as of 18:19:09 ET
CorMedix Inc

CorMedix Inc

Pharmaceuticals
$7.39
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
CRMD
CorMedix Inc
Mon Aug 10 · market closed · Markets closed · resumes Tue 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

73/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Mon Aug 10 · market closed · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CRMD moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CRMD catalysts
About CorMedix Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2010
Employees
191
Country
US

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$7.40
Day high
$7.55
Day low
$7.31
Previous close
$7.44
52W high
$14.83
-50.15% from high
52W low
$6.25
13% of range
Market cap
$583.7M
P/E
3.26×
EPS
$2.27
Beta
0.68
Shares out
78.5M
Volume
842.6K
0.91× rel vol
Avg volume
925K
VWAP
$7.46
Price history computed in-house
1W
-1.70%
1M
-12.00%
3M
-1.44%
1Y
-26.59%
YTD
-36.44%
SMA 50 $8.20 · below
SMA 200 $8.54 · below
52W position 13%

CRMD overview

Veridion Score
73
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CRMD.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CRMD Form 4 filings
Public disclosures

Congress activity in CRMD

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CRMD in the cached public ledger.

Federal contracts

CRMD contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CRMD in this window.
Lobbying spend

CRMD lobbying filings, year to date.

Registered lobbying filings matched to CorMedix Inc.

$750.0K
Refresh interval: 12hSource: LDA disclosure filings
Health Issues
Filing
$380.0K
CORMEDIX INC.

CORMEDIX INC.

Jul 2, 2026
Filing
$220.0K
CORMEDIX INC.

CORMEDIX INC.

Jul 31, 2026
Filing
$150.0K
CORMEDIX INC.

CORMEDIX INC.

Feb 5, 2026
Loading news for CRMD
Analyst ratings
Sovereign unlock shows live analyst consensus for CRMD.
Options
Sovereign unlock shows live options positioning for CRMD.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.